Evidence map›Paper›PMID 40929476›Full record

ArticleJornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia2025

Results of radiotherapy for thymoma: retrospective cohort and propensity score matching analysis.

Jordana de Paula Soares, Gabriel Faria Najas, Geovanne Pedro Mauro, Kennya Medeiros Lopes de Barros Lima, Clarissa Cerchi Angotti Ramos, Pedro Henrique Xavier Nabuco de Araujo, Heloisa de Andrade Carvalho

Abstract read
In one paragraph

Article in Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jordana de Paula Soares. Departamento de Radiologia e Oncologia, Faculdade de Medicina, Universidade de São Paulo, São Paulo (SP) Brasil.ORCID http://orcid.org/0009-0000-1741-3707
Gabriel Faria Najas. Instituto do Câncer do Estado de São Paulo - ICESP - Universidade de São Paulo, São Paulo (SP) Brasil.ORCID http://orcid.org/0000-0003-0760-7107
Geovanne Pedro Mauro. Departamento de Radiologia e Oncologia, Faculdade de Medicina, Universidade de São Paulo, São Paulo (SP) Brasil.ORCID http://orcid.org/0000-0002-2050-3110
Kennya Medeiros Lopes de Barros Lima. Departamento de Radiologia e Oncologia, Faculdade de Medicina, Universidade de São Paulo, São Paulo (SP) Brasil.ORCID http://orcid.org/0009-0004-7361-0245
Clarissa Cerchi Angotti Ramos. Instituto do Câncer do Estado de São Paulo - ICESP - Universidade de São Paulo, São Paulo (SP) Brasil.ORCID http://orcid.org/0009-0003-6851-4323
Pedro Henrique Xavier Nabuco de Araujo. Instituto do Câncer do Estado de São Paulo - ICESP - Universidade de São Paulo, São Paulo (SP) Brasil.ORCID http://orcid.org/0000-0003-0817-8180
Heloisa de Andrade Carvalho. Departamento de Radiologia e Oncologia, Faculdade de Medicina, Universidade de São Paulo, São Paulo (SP) Brasil.ORCID http://orcid.org/0000-0003-0979-7768

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThymic tumors are a rare group of anterior mediastinal tumors. Surgery is the primary treatment. Adjuvant treatment is used in select cases. The purpose of this study was to evaluate the outcomes of patients with thymic tumors, submitted or not to radiotherapy, and identify risk factors that could impact the outcomes to better support patient selection for RT.

methodsThis is a single institution retrospective cohort study. Patients with histologically proven thymoma or thymic carcinoma treated from July of 2009 to November of 2020 were included. Analysis was based on the use of radiation therapy (RT). Overall survival and disease-free survival were assessed from the date of diagnosis. To minimize selection bias, propensity score matching (PSM) regression using Kernel matching was used, estimated on the population for average treatment effect.

resultsOverall, 101 patients were analyzed, with mean age at diagnosis of 54.6 years (range 25-84 years). Unfavorable histology and more advanced stages predominated in the cohort. Nevertheless, most (69.3%) were treated with radical intent. RT was delivered in 52.9% of these patients. Five-year OS, local progression and distant progression free survivals were 81.0%, 95.0% and 88.1%, respectively for the radical intent cohort. PSM showed that RT reduced the chances of death by 6.3% (matched sample size was 60, p = 0.02).

conclusionsIn this retrospective cohort, RT had a positive impact in OS after PSM analysis. Prospective data regarding the role of RT in this disease is needed to validate these findings.

Indexed as

ThymomaThymus NeoplasmsAdultAgedAged, 80 and overDisease-Free SurvivalFemaleHumansMaleMiddle AgedPropensity ScoreRetrospective StudiesRisk FactorsTreatment Outcome

Identifiers

PMID40929476
PMCPMC12401149

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.